SCHEMBL31220002

SCHEMBL31220002

CCC1(C)C(=O)Nc2cc(Br)ccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
CMA1 P23946 1/20 0.41
AHR P35869 1/20 0.41
PIM1 P11309 2/20 0.41
PIM3 Q86V86 1/20 0.40
PIM2 Q9P1W9 1/20 0.40
GAA P10253 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 2/20 0.38
TP53 P04637 1/20 0.37
ALDH1A1 P00352 2/20 0.36
HTR6 P50406 2/20 0.35
AKR1B1 P15121 1/20 0.35
PKM P14618 1/20 0.35
USP2 O75604 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TGM2 P21980 1/20 0.35
CES1 P23141 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5499896 0.87 LMNA (0.48) MEN1KMT2AGAAL3MBTL1LMNA
SCHEMBL31220147 0.85 MEN1 (0.46) MEN1KMT2ACMA1AHRPIM1
SCHEMBL5497405 0.83 MAPT (0.48) MEN1KMT2AGAAL3MBTL1LMNA
SCHEMBL31219731 0.83 MEN1 (0.44) MEN1KMT2ACMA1AHRPIM1
SCHEMBL1613300 0.81 MEN1 (0.40) MEN1KMT2ACMA1AHRPIM1
SCHEMBL13825600 0.81 AKR1B1 (0.43) MEN1KMT2AGAATP53ALDH1A1
SCHEMBL2242471 0.81 MEN1 (0.45) MEN1KMT2ACMA1AHRPIM1
SCHEMBL25805362 0.81 AKR1B1 (0.43) MEN1KMT2AGAATP53ALDH1A1
SCHEMBL31079959 0.81 MEN1 (0.45) MEN1KMT2ACMA1AHRPIM1
SCHEMBL1613237 0.80 MEN1 (0.42) MEN1KMT2ACMA1AHRPIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4713096-A1 CDK INHIBITOR COMPOUNDS Aleksia Therapeutics, Inc. (US) 2026-03-25 EP disclosed
CN-119330982-A Azetidine compound and medical application thereof 中国科学院上海药物研究所 2025-01-21 CN disclosed
WO-2024238574-A1 CDK INHIBITOR COMPOUNDS ALEKSIA THERAPEUTICS, INC. (US) 2024-11-21 WO disclosed